Last reviewed · How we verify
Triiodothyronine
At a glance
| Generic name | Triiodothyronine |
|---|---|
| Also known as | Cytomel, Tetronine, Lyothyronine |
| Sponsor | Northwell Health |
| Target | THAP domain-containing protein 1, Cytochrome P450 2C9, Proliferating cell nuclear antigen |
| Modality | Small molecule |
| Therapeutic area | Oncology |
| Phase | FDA-approved |
Approved indications
- Congenital hypothyroidism
- Diagnostic Test for Thyroid Dysfunction
- Goiter
- Hypothyroidism
- Malignant tumor of thyroid gland
- Mild Hypothyroidism
- Myxedema
- Myxedema coma
- Simple goiter
- T3 Suppression for Thyroid Function Test
Common side effects
Key clinical trials
- Comparison Of The Effects Of Regional Anesthesia On Brain And Carotid Artery Oxygenation In Shoulder Surgery (NA)
- Internet-based Mindfulness-based Training (iMBT) for People With Depression (NA)
- Chemotherapy Before Surgery and Radiation Therapy or Surgery and Radiation Therapy Alone in Treating Patients With Nasal and Paranasal Sinus Cancer That Can Be Removed by Surgery (PHASE2)
- Characterization and Support of Neurodevelopmental Disorders Associated With Congenital Cardiac malfoRmations - Neonatal
- A Study of the Impact of Endocrine Therapy on Surgical Outcomes in People With Breast Cancer (PHASE2)
- Effect of Physical Activity Program on Sedentary of Patients With Upper Aerodigestive Tract Cancer (NA)
- Paravertebral Block for Mastectomy With Immediate Reconstruction (NA)
- Novel Approaches to the Treatment of Hypothyroidism (PHASE2, PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |